(Total Views: 148)
Posted On: 06/03/2022 3:15:51 PM
Post# of 47159

$SGEN News Article - ADCETRIS (brentuximab vedotin) Plus Standard of Care Chemotherapy Demonstrates Superior Event-Free Survival (EFS) vs. Standard of Care Alone in Children and Young Adults with Previously Untreated High-Risk Hodgkin Lymphoma https://marketwirenews.com/news-releases/adce...99102.html


My Twitter: WhyteStocks